Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OS2006 zoledronic acid in osteosarcoma
2006-003377-27Phase 3Active
- Sponsor
- Unicancer
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of zoledronic acid in osteosarcoma (OS) (2 arms), sponsored by Unicancer. Primary endpoint: Event-free survival. Started Aug 2006; status: active.
02
Drugs
zoledronic acid
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on 2006-003377-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003377-27.